AAAAAA

   
Results: 1-7 |
Results: 7
BIOCHEMICAL-MECHANISMS OF IL-2-REGULATED FAS-MEDIATED T-CELL APOPTOSIS
Authors: REFAELI Y VANPARIJS L LONDON CA TSCHOPP J ABBAS AK
Citation: Y. Refaeli et al., BIOCHEMICAL-MECHANISMS OF IL-2-REGULATED FAS-MEDIATED T-CELL APOPTOSIS, Immunity, 8(5), 1998, pp. 615-623
HELPER T-CELL SUBSETS - HETEROGENEITY, FUNCTIONS AND DEVELOPMENT
Authors: LONDON CA ABBAS AK KELSO A
Citation: Ca. London et al., HELPER T-CELL SUBSETS - HETEROGENEITY, FUNCTIONS AND DEVELOPMENT, Veterinary immunology and immunopathology, 63(1-2), 1998, pp. 37-44
ROLE OF INTERLEUKIN-12 AND COSTIMULATORS IN T-CELL ANERGY IN-VIVO
Authors: PARIJS LV PEREZ VL BIUCKIANS A MAKI RG LONDON CA ABBAS AK
Citation: Lv. Parijs et al., ROLE OF INTERLEUKIN-12 AND COSTIMULATORS IN T-CELL ANERGY IN-VIVO, The Journal of experimental medicine, 186(7), 1997, pp. 1119-1128
ASSESSMENT OF POTENTIAL DOUBLING TIME (T-POT), ARGYROPHILIC NUCLEOLARORGANIZER REGIONS (AGNOR), AND PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) AS PREDICTORS OF THERAPY RESPONSE IN CANINE NON-HODGKINS-LYMPHOMA
Authors: VAIL DM KISSEBERTH WC OBRADOVICH JE MOORE FM LONDON CA MACEWEN EG RITTER MA
Citation: Dm. Vail et al., ASSESSMENT OF POTENTIAL DOUBLING TIME (T-POT), ARGYROPHILIC NUCLEOLARORGANIZER REGIONS (AGNOR), AND PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) AS PREDICTORS OF THERAPY RESPONSE IN CANINE NON-HODGKINS-LYMPHOMA, Experimental hematology, 24(7), 1996, pp. 807-815
EXPRESSION OF STEM-CELL FACTOR-RECEPTOR (C-KIT) BY THE MALIGNANT MAST-CELLS FROM SPONTANEOUS CANINE MAST-CELL TUMORS
Authors: LONDON CA KISSEBERTH WC GALLI SJ GEISSLER EN HELFAND SC
Citation: Ca. London et al., EXPRESSION OF STEM-CELL FACTOR-RECEPTOR (C-KIT) BY THE MALIGNANT MAST-CELLS FROM SPONTANEOUS CANINE MAST-CELL TUMORS, Journal of Comparative Pathology, 115(4), 1996, pp. 399-414
EVALUATION OF DOGS AND CATS WITH TUMORS OF THE EAR CANAL - 145 CASES (1978-1992)
Authors: LONDON CA DUBILZEIG RR VAIL DM OGILVIE GK HAHN KA BREWER WG HAMMER AS OKEEFE DA CHUN R MCENTEE MC MCCAW DL FOX LE NORRIS AM KLAUSNER JS
Citation: Ca. London et al., EVALUATION OF DOGS AND CATS WITH TUMORS OF THE EAR CANAL - 145 CASES (1978-1992), Journal of the American Veterinary Medical Association, 208(9), 1996, pp. 1413
LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE ADJUVANT IMMUNOTHERAPY FOR SPLENIC HEMANGIOSARCOMA IN THE DOG - A RANDOMIZED MULTIINSTITUTIONAL CLINICAL-TRIAL
Authors: VAIL DM MACEWEN EG KURZMAN ID DUBIELZIG RR HELFAND SC KISSEBERTH WC LONDON CA OBRADOVICH JE MADEWELL BR RODRIGUEZ CO FIDEL J SUSANECK S ROSENBERG M
Citation: Dm. Vail et al., LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE ADJUVANT IMMUNOTHERAPY FOR SPLENIC HEMANGIOSARCOMA IN THE DOG - A RANDOMIZED MULTIINSTITUTIONAL CLINICAL-TRIAL, Clinical cancer research, 1(10), 1995, pp. 1165-1170
Risultati: 1-7 |